Advertisement
UK markets close in 6 hours 7 minutes

  • FTSE 100

    8,046.78
    +22.91 (+0.29%)
     

  • FTSE 250

    19,675.98
    +76.59 (+0.39%)
     

  • AIM

    751.73
    +2.55 (+0.34%)
     

  • GBP/EUR

    1.1596
    +0.0007 (+0.06%)
     

  • GBP/USD

    1.2361
    +0.0011 (+0.09%)
     

  • Bitcoin GBP

    53,603.26
    +248.87 (+0.47%)
     

  • CMC Crypto 200

    1,395.96
    -18.80 (-1.33%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    82.30
    +0.40 (+0.49%)
     

  • GOLD FUTURES

    2,310.40
    -36.00 (-1.53%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    17,960.66
    +99.86 (+0.56%)
     

  • CAC 40

    8,066.66
    +26.30 (+0.33%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Roche extends offer deadline for Spark Therapeutics again

Reuters
FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

ZURICH (Reuters) - Roche <ROG.S> has again extended the deadline for its tender offer for Spark Therapeutics <ONCE.O>, the Swiss drugmaker said on Friday, saying U.S. and British anti-trust authorities needed more time to review the deal.

The offer, which was originally due to expire on Nov. 25, has now been extended to Dec. 10. All terms and conditions of the offer remain the same, Roche said. So far 14.8% of the shares were tendered.

Roche has put back the deadline several times since it announced the $4.3 billion offer to buy the gene therapy company in February.

(Reporting by John Revill; Editing by Michael Shields)